We are live on !
Find out more
Peregrine Asset Advisers Portfolio holdings
AUM
$435M
Turnover
19.34%
1-Year Est. Return
32.22%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+32.22%
3 Year Est. Return
+188.97%
5 Year Est. Return
+270.41%
10 Year Est. Return
+1,974.56%
AUM
$435M
AUM Growth
-$26.4M
(-5.7%)
Cap. Flow
-$25M
Cap. Flow % of AUM
Cap. Flow %
-5.76%
Top 10 Holdings %
Top 10 Hldgs %
31.6%
Holding
243
New
25
Increased
64
Reduced
74
Closed
22
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$4.83M |
| 2 |
Micron Technology
MU
|
+$4.49M |
| 3 |
VanEck Agribusiness ETF
MOO
|
+$4.43M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.31M |
| 5 |
Hewlett Packard
HPE
|
+$3.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$7.62M |
| 2 |
ASML
ASML
|
+$7.32M |
| 3 |
EOG Resources
EOG
|
+$6.98M |
| 4 |
PepsiCo
PEP
|
+$6.05M |
| 5 |
Comfort Systems
FIX
|
+$5.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.6% |
| 2 | Technology | 17.98% |
| 3 | Industrials | 10.72% |
| 4 | Healthcare | 7.18% |
| 5 | Financials | 4.27% |
Similar funds
LCM
NICM
DCM
CEI
Peregrine Asset Advisers's Q3 2026 Portfolio in Review
As of Q3 2026, Peregrine Asset Advisers held 243 positions worth $435M, down 5.7% from $461M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Peregrine Asset Advisers withdrew a net $25M in Q3 2026, closing 22 positions and reducing 74 holdings. Its most notable exit was EOG Resources, an estimated $6.98M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 40% a quarter earlier, followed by Technology and Industrials.
Against the trend, Peregrine Asset Advisers opened a new position in VanEck Agribusiness ETF worth $4.33M.
- Peregrine Asset Advisers's largest Q3 2026 buy was VanEck Agribusiness ETF: 53,129 shares worth $4.33M.
- Peregrine Asset Advisers added most to Vertex Pharmaceuticals in Q3 2026, an estimated $4.83M increase.
- Peregrine Asset Advisers's biggest Q3 2026 reduction was Merck, cutting an estimated $7.62M.
- Peregrine Asset Advisers fully exited EOG Resources in Q3 2026, selling an estimated $6.98M.
- Peregrine Asset Advisers's ten largest holdings make up 32% of its $435M portfolio in Q3 2026.
- Peregrine Asset Advisers opened 25 new positions and closed 22 in Q3 2026.
- Peregrine Asset Advisers's portfolio value fell 5.7% quarter-over-quarter to $435M.
Based on Peregrine Asset Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.